相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M. J. Ward et al.
BRITISH JOURNAL OF CANCER (2014)
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
Geok Choo Sim et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The Genetics of Melanoma: Recent Advances
Victoria K. Hill et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 14 (2013)
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
D. Bedognetti et al.
BRITISH JOURNAL OF CANCER (2013)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?
C. M. Nijenhuis et al.
CANCER TREATMENT REVIEWS (2013)
Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture
Michael Apel et al.
CHEMIE INGENIEUR TECHNIK (2013)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach
Diwakar Davar et al.
CLINICS IN DERMATOLOGY (2013)
Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
Nancy E. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy
Simon Turcotte et al.
JOURNAL OF IMMUNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes
Travis E. Grotz et al.
MELANOMA RESEARCH (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling
Ingrid Cifola et al.
PLOS ONE (2013)
Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors
Nadine Norton et al.
PLOS ONE (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2012)
Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
Xin Yao et al.
BLOOD (2012)
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy
Gustav J. Ullenhag et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients
Laszlo G. Radvanyi et al.
CLINICAL CANCER RESEARCH (2012)
Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma
Alena Gros et al.
CLINICAL CANCER RESEARCH (2012)
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant
Andrea Velardi et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Wei-Ting Hwang et al.
GYNECOLOGIC ONCOLOGY (2012)
IFN-α in the Treatment of Melanoma
Ahmad A. Tarhini et al.
JOURNAL OF IMMUNOLOGY (2012)
Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
Jianjian Jin et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Eva Ellebaek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
Aude G. Chapuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
Steven A. Rosenberg
SCIENCE TRANSLATIONAL MEDICINE (2012)
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel et al.
ONCOIMMUNOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
mRNA transcript quantification in archival samples using multiplexed, color-coded probes
Patricia P. Reis et al.
BMC BIOTECHNOLOGY (2011)
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
Niels Halama et al.
CANCER RESEARCH (2011)
Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy
Richard W. Joseph et al.
CLINICAL CANCER RESEARCH (2011)
Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma
Geoffrey R. Weiss et al.
CLINICAL CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Kristine H. Allin et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
SSTR2-Based Reporters for Assessing Gene Transfer into Non-Small Cell Lung Cancer: Evaluation Using an Intrathoracic Mouse Model
S. P. Singh et al.
HUMAN GENE THERAPY (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation
Harry Z. Qui et al.
JOURNAL OF IMMUNOLOGY (2011)
Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function
Jessica Ann Hernandez-Chacon et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
Qunrui Ye et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know
Steven A. Rosenberg
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
Marcus O. Butler et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Treating cancer with genetically engineered T cells
Tristen S. Park et al.
TRENDS IN BIOTECHNOLOGY (2011)
Adoptive Therapy Using Antigen-Specific T-Cell Clones
Cassian Yee
CANCER JOURNAL (2010)
Integration of Host-Related Signatures with Cancer Cell-Derived Predictors for the Optimal Management of Anticancer Chemotherapy
Laurence Zitvogel et al.
CANCER RESEARCH (2010)
CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Mark E. Dudley et al.
CLINICAL CANCER RESEARCH (2010)
Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2010)
Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
Juan F. Vera et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells
Claudia Wrzesinski et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Tumor-Infiltrating Foxp3+Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
Katsuhiko Shimizu et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Overlap and Effective Size of the Human CD8+ T Cell Receptor Repertoire
Harlan S. Robins et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan S. Robins et al.
BLOOD (2009)
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Marianna Sabatino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients
Michal J. Besser et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Costimulation Signals for Memory CD8(+) T Cells During Viral Infections
Priyanka A. Duttagupta et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
The impact of T-cell immunity on ovarian cancer outcomes
Brad H. Nelson
IMMUNOLOGICAL REVIEWS (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells
Shahram Salek-Ardakani et al.
JOURNAL OF IMMUNOLOGY (2008)
Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade
Willemijn B. Breunis et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
Gabricla Alexe et al.
CANCER RESEARCH (2007)
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M. Suhoski et al.
MOLECULAR THERAPY (2007)
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell
Marcus O. Butler et al.
CLINICAL CANCER RESEARCH (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
Xinglei Shen et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells
L Myers et al.
INTERNATIONAL IMMUNOLOGY (2006)
Tumor antigen expression in melanoma varies according to antigen and stage
C Barrow et al.
CLINICAL CANCER RESEARCH (2006)
4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells
YH Kim et al.
CELLULAR IMMUNOLOGY (2005)
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
JP Huang et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bcl-2 overexpression enhances tumor-specific T-cell survival
J Charo et al.
CANCER RESEARCH (2005)
Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
DJ Powell et al.
BLOOD (2005)
Immunotherapy for gynaecological malignancies
G Coukos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Persistence of multiple tumor-specific T-Cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOTHERAPY (2005)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley et al.
NATURE REVIEWS CANCER (2003)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Selective modification of antigen-specific CD4+ T cells by retroviral-mediated gene transfer and in vitro sensitization with dendritic cells
CM Lin et al.
CLINICAL IMMUNOLOGY (2002)
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection
EM Bertram et al.
JOURNAL OF IMMUNOLOGY (2002)
Retroviral transduction of human peripheral blood lymphocytes with bcl-xL promotes in vitro lymphocyte survival in pro-apoptotic conditions
D Eaton et al.
GENE THERAPY (2002)
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB
MV Maus et al.
NATURE BIOTECHNOLOGY (2002)
分享论文
